Ashleigh Tuite
Assistant Professor
University of Toronto Dalla Lana School of Public Health




Senior Epidemiologist
BlueDot Inc.


Postdoctoral Research Fellow (previously held)
Boston Medical Center
Medicine
Infectious Diseases

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Rudd M, Simmons AE, Gebretekle GB, Tuite AR. Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison. Can Commun Dis Rep. 2025 Feb; 51(2-3):54-67. PMID: 39991551; PMCID: PMC11845172; DOI: 10.14745/ccdr.v51i23a01;
     
  2. Simmons AE, Gebretekle GB, Pless R, Wierzbowski A, Tunis M, Tuite AR. Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis. Can Commun Dis Rep. 2025 Feb; 51(2-3):68-83. PMID: 39980573; PMCID: PMC11842121; DOI: 10.14745/ccdr.v51i23a02;
     
  3. Simmons AE, Ximenes R, Gebretekle GB, Salvadori MI, Wong E, Tuite AR. Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations. Can Commun Dis Rep. 2025 Feb; 51(2-3):84-91. PMID: 39980572; PMCID: PMC11839088; DOI: 10.14745/ccdr.v51i23a03;
     
  4. Aglipay M, Maguire JL, Swayze S, Tuite A, Mamdani M, Keown-Stoneman C, Birken CS, Kwong JC. Initial Effectiveness of mRNA-1273 Against SARS-CoV-2 Infection and Hospitalization in Young Children. Open Forum Infect Dis. 2025 Jan; 12(1):ofae718. PMID: 39758749; PMCID: PMC11697100; DOI: 10.1093/ofid/ofae718;
     
  5. Drolet M, Laprise JF, Chamberland É, Sauvageau C, Wilson S, Lim GH, Ogilvie G, Tuite A, Brisson M. Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis. CMAJ. 2024 Oct 06; 196(33):E1136-E1143. PMID: 39374971; PMCID: PMC11464022; DOI: 10.1503/cmaj.240787;
     
  6. Ogden NH, Acheson ES, Brown K, Champredon D, Colijn C, Diener A, Dushoff J, Earn DJ, Gabriele-Rivet V, Gangbè M, Guillouzic S, Hennessy D, Hongoh V, Hurford A, Kanary L, Li M, Ng V, Otto SP, Papst I, Rees EE, Tuite A, MacLeod MR, Murall CL, Waddell L, Wasfi R, Wolfson M. Mathematical modelling for pandemic preparedness in Canada: Learning from COVID-19. Can Commun Dis Rep. 2024 Oct; 50(10):345-356. PMID: 39380801; PMCID: PMC11460797; DOI: 10.14745/ccdr.v50i10a03;
     
  7. Tuite AR, Simmons AE, Rudd M, Cernat A, Gebretekle GB, Yeung MW, Killikelly A, Siu W, Buchan SA, Brousseau N, Tunis M. Respiratory syncytial virus vaccination strategies for older Canadian adults: a cost-utility analysis. CMAJ. 2024 Sep 09; 196(29):E989-E1005. PMID: 39251240; PMCID: PMC11383547; DOI: 10.1503/cmaj.240452;
     
  8. Aglipay M, Kwong JC, Colwill K, Gringas AC, Tuite A, Mamdani M, Keown-Stoneman C, Birken C, Maguire J. Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario. Can J Public Health. 2024 Dec; 115(6):913-923. PMID: 39168962; PMCID: PMC11644124; DOI: 10.17269/s41997-024-00916-3;
     
  9. Gebretekle GB, Yeung MW, Ximenes R, Cernat A, Simmons AE, Killikelly A, Siu W, Rafferty E, Brousseau N, Tunis M, Tuite AR. Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants. Vaccine. 2024 Aug 30; 42(21):126164. PMID: 39079810
     
  10. Fisman DN, Simmons AE, Tuite AR. Case-cohort design as an efficient approach to evaluating COVID-19 vaccine effectiveness, waning, heterologous immune effect and optimal dosing interval. Vaccine. 2024 Nov 14; 42(25):126134. PMID: 39004528
     
Showing 10 of 129 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 129 publications over 21 distinct years, with a maximum of 24 publications in 2020

YearPublications
20031
20042
20052
20061
20093
20106
20117
20122
20139
20145
20151
20162
20175
20184
201910
202024
202111
202212
20239
202410
20253

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.
Contact for Mentoring:

Tuite's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_